À propos
Actions
Données et outils
Évenements
Actualités

La deuxième édition du Sommet mondial de la FMH sur les politiques et l’accès aux traitements se tiendra les 27 et 28 octobre 2022. Rejoignez‑nous, vous et vos collègues, pour :

  1. Partager des stratégies de soutien et de renforcement de l’offre de soins dans le domaine des troubles de la coagulation dans un monde en constante évolution et en proie à une pandémie.
  2. Promouvoir le dialogue et le partage des connaissances entre les organisations nationales membres (ONM), les professionnels de santé et les instances gouvernementales.

Lors de ce sommet virtuel organisé sur deux jours, les présentations et les discussions seront axées sur l’amélioration de l’offre de soins et sur l’accès aux traitements. La conférence réunira des intervenants et des participants issus d’organisations partenaires locales et internationales, des représentants des instances gouvernementales, des professionnels de santé, des dirigeants d’ONM de la FMH et des représentants associatifs des troubles de la coagulation.

Sommet mondial de la FMH sur les politiques et l’accès aux traitements est une occasion unique de s’informer, de discuter et d’échanger des connaissances sur les stratégies visant à accroître l’accès équitable aux soins et aux traitements pour la communauté mondiale concernée par les troubles de la coagulation. Nous sommes impatients de vous rencontrer virtuellement en octobre prochain !

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.